rs397514721
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP2PP5_Very_Strong
The NM_080605.4(B3GALT6):c.925T>A(p.Ser309Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000144 in 1,388,346 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_080605.4 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndrome, spondylodysplastic type, 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
- spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fracturesInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spondyloepimetaphyseal dysplasia with joint laxityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 135418 AF XY: 0.00
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1388346Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 685544 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Published functional studies demonstrate a significant decrease in enzyme activity (PMID: 23664117); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29443383, 29931299, 31614862, 23664117, 31589614) -
Ehlers-Danlos syndrome, spondylodysplastic type, 2 Pathogenic:1
- -
Spondyloepimetaphyseal dysplasia with joint laxity;C3809210:Ehlers-Danlos syndrome, spondylodysplastic type, 2 Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 309 of the B3GALT6 protein (p.Ser309Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal recessive Ehlers-Danlos syndrome (PMID: 23664117, 29931299, 31614862). ClinVar contains an entry for this variant (Variation ID: 60491). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Studies have shown that this missense change alters B3GALT6 gene expression (PMID: 23664117). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at